•
Dec 31, 2018

CRISPR Therapeutics Q4 2018 Earnings Report

Total Revenue
$115K
Previous year: $32.3M
-99.6%
EPS
-$0.92
Previous year: $0.00307
-30067.4%
Gross Profit
-$28.7M
Previous year: $12.3M
-333.3%
Cash and Equivalents
$457M
Previous year: $240M
+90.5%
Free Cash Flow
-$29.4M
Previous year: -$15M
+95.2%
Total Assets
$489M
Previous year: $271M
+80.2%

CRISPR Therapeutics

CRISPR Therapeutics